BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 33147563)

  • 1. Pulmonary nodules in patients with primary Sjögren's syndrome: Causes, clinico-radiologic features, and outcomes.
    Casal Moura M; Navin PJ; Johnson GB; Hartman TE; Baqir M; Yi ES; Ryu JH
    Respir Med; 2020; 174():106200. PubMed ID: 33147563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A case of solitary pulmonary nodular amyloidosis with Sjögren's syndrome.
    Sowa T; Komatsu T; Fujinaga T; Kato T
    Ann Thorac Cardiovasc Surg; 2013; 19(3):247-9. PubMed ID: 22971705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The maximum standardized uptake values on integrated FDG-PET/CT is useful in differentiating benign from malignant pulmonary nodules.
    Bryant AS; Cerfolio RJ
    Ann Thorac Surg; 2006 Sep; 82(3):1016-20. PubMed ID: 16928527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FDG-PET/CT discriminates between patients with and without lymphomas in primary Sjögren's syndrome.
    van Ginkel MS; Arends S; van der Vegt B; Nijland M; Spijkervet FKL; Vissink A; Kroese FGM; Glaudemans AWJM; Bootsma H
    Rheumatology (Oxford); 2023 Oct; 62(10):3323-3331. PubMed ID: 36759907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amyloid-associated cystic lung disease in primary Sjögren's syndrome.
    Baqir M; Kluka EM; Aubry MC; Hartman TE; Yi ES; Bauer PR; Ryu JH
    Respir Med; 2013 Apr; 107(4):616-21. PubMed ID: 23402779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonary nodules as initial manifestation of primary Sjogren's syndrome.
    Reuss-Borst MA; Hartmann U
    Ann Rheum Dis; 2006 May; 65(5):685-7. PubMed ID: 16611868
    [No Abstract]   [Full Text] [Related]  

  • 7. Primary Sjögren's syndrome is associated with increased risk of malignancies besides lymphoma: A systematic review and meta-analysis.
    Zhong H; Liu S; Wang Y; Xu D; Li M; Zhao Y; Zeng X
    Autoimmun Rev; 2022 May; 21(5):103084. PubMed ID: 35341972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The relationship between Sjogren's syndrome, systemic sclerosis and lymphoproliferative diseases].
    Vasil'ev VI; Chal'tsev BD; Gorodetskii VR; Pal'shina SG; Shornikova NS; Anan'eva LP; Gaiduk IV; Kokosadze NV; Probatova NA; Pavlovskaia AI; Rodionova EB; Safonova TN; Balabina AA
    Ter Arkh; 2020 Dec; 92(12):126-136. PubMed ID: 33720584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Value of [18F]-FDG-PET/CT as a predictor of cancer in solitary pulmonary nodule].
    Martins Rde C; Almeida SA; Siciliano AA; Landesmann MC; Silva FB; Franco CA; Fonseca LM
    J Bras Pneumol; 2008 Jul; 34(7):473-80. PubMed ID: 18695792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low miR200b-5p levels in minor salivary glands: a novel molecular marker predicting lymphoma development in patients with Sjögren's syndrome.
    Kapsogeorgou EK; Papageorgiou A; Protogerou AD; Voulgarelis M; Tzioufas AG
    Ann Rheum Dis; 2018 Aug; 77(8):1200-1207. PubMed ID: 29779010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Usefulness of
    Keraen J; Blanc E; Besson FL; Leguern V; Meyer C; Henry J; Belkhir R; Nocturne G; Mariette X; Seror R
    Arthritis Rheumatol; 2019 Jul; 71(7):1147-1157. PubMed ID: 30615273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Small solitary pulmonary nodules: assessment of enhancement and enhancement patterns in benign and malignant tumours by high resolution computed tomography.
    Potente G; D'Andrea V; Cantisani V; Berni A; De Antoni E
    Chir Ital; 1999; 51(2):113-20. PubMed ID: 10514926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentiation between malignancy and inflammation in pulmonary ground-glass nodules: The feasibility of integrated (18)F-FDG PET/CT.
    Chun EJ; Lee HJ; Kang WJ; Kim KG; Goo JM; Park CM; Lee CH
    Lung Cancer; 2009 Aug; 65(2):180-6. PubMed ID: 19155090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics of primary Sjögren's syndrome related lymphocytic interstitial pneumonia.
    Dong X; Gao YL; Lu Y; Zheng Y
    Clin Rheumatol; 2021 Feb; 40(2):601-612. PubMed ID: 32613392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics of patients with primary Sjögren's syndrome associated interstitial lung disease and relevant features of disease progression.
    Zhang T; Yuan F; Xu L; Sun W; Liu L; Xue J
    Clin Rheumatol; 2020 May; 39(5):1561-1568. PubMed ID: 31902032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bilateral pulmonary nodules and mediastinal lymphadenopathy in a patient with Sjogren's syndrome.
    Pathak V; Resnick JM; Islam T
    WMJ; 2014 Feb; 113(1):32-4. PubMed ID: 24712219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphoma in Sjogren's syndrome.
    Pavlidis NA; Drosos AA; Papadimitriou C; Talal N; Moutsopoulos HM
    Med Pediatr Oncol; 1992; 20(4):279-83. PubMed ID: 1608349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Likelihood of malignancy in a solitary pulmonary nodule: comparison of Bayesian analysis and results of FDG-PET scan.
    Dewan NA; Shehan CJ; Reeb SD; Gobar LS; Scott WJ; Ryschon K
    Chest; 1997 Aug; 112(2):416-22. PubMed ID: 9266877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical features distinguishing lymphoma development in primary Sjögren's Syndrome--a retrospective cohort study.
    Risselada AP; Kruize AA; Bijlsma JW
    Semin Arthritis Rheum; 2013 Oct; 43(2):171-7. PubMed ID: 23664530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lung involvement in patients with primary Sjögren's syndrome: what are the predictors?
    Yazisiz V; Arslan G; Ozbudak IH; Turker S; Erbasan F; Avci AB; Ozbudak O; Terzioglu E
    Rheumatol Int; 2010 Aug; 30(10):1317-24. PubMed ID: 19844720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.